EPIDEMIOLOGY AND RISK FACTORS FOR EXTRAHEPATIC CHOLANGIOCARCINOMA IN THE ABSENCE OF VIRAL HEPATITIS AND PRIMARY SCLEROSING CHOLANGITIS

被引：0

作者：

Abdelhakeem, Ahmed ^{[1
]}

Hatia, Rikita ^{[2
]}

Eluri, Madulika ^{[3
]}

Shalaby, Ahmed ^{[4
]}

Karatas, Elif ^{[5
]}

Shalaby, Akram ^{[6
]}

Jalal, Prasun K. ^{[7
]}

Shroff, Rachna T. ^{[8
]}

Hawk, Ernest ^{[9
]}

Li, Donghui ^{[10
]}

Javle, Milind ^{[10
]}

Hassan, Manal M. ^{[2
]}

机构：

[1] Baptist Hosp Southeast Texas, Dept Internal Med, Beaumont, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Heamtol Oncol Fellowship, Houston, TX USA

[4] Robert Wood Johnson Univ Hosp, Dept Radiat Oncol, New Brunswick, NJ USA

[5] Jacobi Med Ctr, Dept Internal Med, New York, NY USA

[6] Case Western Reserve Univ, Dept Pathol, Cleveland, OH USA

[7] Baylor Coll Med, Div Gastroenterol & Hepatol, Houston, TX USA

[8] Univ Arizona, Div Hematol Oncol, Coll Med, Tucson, AZ USA

[9] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent Populat Sci, Houston, TX USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4427

引用

页码：S1325 / S1326

页数：2

共 50 条

[21] Extrahepatic and extraintestinal manifestations of primary sclerosing cholangitis
Lohse, W
Schramm, C
Boberg, KM
CHOLESTATIC LIVER DISEASES: THERAPEUTIC OPTIONS AND PERSPECTIVES: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 136 : 289 - 292
[22] Hepatic and extrahepatic malignancies and primary sclerosing cholangitis
Schrumpf, E
Boberg, KM
GUT, 2003, 52 (02) : 165 - 165
[23] Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A
Ekbom, A
Olsson, R
Kornfeldt, D
Lööf, L
Danielsson, Å
Hultcrantz, R
Lindgren, S
Prytz, H
Sandberg-Gertzén, H
Almer, S
Granath, F
Broomé, U
JOURNAL OF HEPATOLOGY, 2002, 36 (03) : 321 - 327
[24] No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
Zenouzi, Roman
Weismueller, Tobias J.
Jorgensen, Kristin K.
Bubenheim, Michael
Lenzen, Henrike
Huebener, Peter
Schulze, Kornelius
Weiler-Normann, Christina
Sebode, Marcial
Ehlken, Hanno
Pannicke, Nadine
Hartl, Johannes
Peiseler, Moritz
Huebener, Sina
Karlsen, Tom H.
Boberg, Kirsten M.
Manns, Michael P.
Lohse, Ansgar W.
Schramm, Christoph
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) : 1806 - 1812
[25] Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk
Nanjundappa, Roopa H.
Christen, Urs
Umeshappa, Channakeshava S.
HEPATOLOGY COMMUNICATIONS, 2023, 7 (09)
[26] Environmental Risk Factors of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Hepatitis
Tenca, Andrea
Farkkila, Martti
Jalanko, Hannu
Vapalahti, Katariina
Arola, Johanna
Jaakkola, Tytti
Penagini, Roberto
Vapalahti, Olli
Kolho, Kaija-Leena
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (03): : 437 - 442
[27] Colon cancer and cholangiocarcinoma in primary sclerosing cholangitis
Weismueller, T. J.
Lankisch, T. O.
Voigtlaender, T.
GASTROENTEROLOGE, 2015, 10 (01): : 26 - 31
[28] Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis
Siqueira, E
Schoen, RE
Silverman, W
Martini, J
Rabinovitz, M
Weissfeld, JL
Abu Elmaagd, K
Madariaga, JR
Slivka, A
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (01) : 40 - 47
[29] Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis
Caldwell, SH
Bickston, SJ
LIVER TRANSPLANTATION, 2001, 7 (04) : 380 - 380
[30] Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis
Steven A. Ahrendt
Henry A. Pitt
Attila Nakeeb
Andrew S. Klein
Keith D. Lillemoe
Anthony N. Kalloo
John L. Cameron
Journal of Gastrointestinal Surgery, 1999, 3 : 357 - 368

← 1 2 3 4 5 →